A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Recruiting · Phase 3 · NCT04965675
Conditions: Chronic Migraine in Children
At a glance
- Research payments reported, 2025
- $332,859
- U.S. investigators named
- 17
- Sites paid
- 15
- Planned or actual enrollment
- 285
About the trial
- Sponsor
- H. Lundbeck A/S
- Tested
- Eptinezumab (drug), Placebo (drug)
- Dates
- Started 2021-06-30; completion 2027-03-26
- Results posted
- Not yet
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
From ClinicalTrials.gov, last updated 2026-10-16. Full record, eligibility and contacts (opens in a new tab)
Industry funding
H. Lundbeck A S reported $332,859 in research payments for this study in 2025 (91 payments).
Products named: Vyepti
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Cristian Ionita, MD Child Neurology · Hartford, CT
- Kathleen B. Mullin, M.D. Neurology · Stamford, CT
- Dario D. Altamirano, DO Family Medicine · Hialeah, FL
- Janice Y. Maldonado, MD Neurology · Tampa, FL
- Weldon A. Mauney III, M.D. Child Neurology · Gulf Breeze, FL
- James B. Renfroe, MD Child Neurology · Gulf Breeze, FL
- Sharoon Qaiser, M.D. Child Neurology · Lexington, KY
- Jack Gladstein, MD Child Neurology · Baltimore, MD
- Steven T. Deroos, MD Child Neurology · Grand Rapids, MI
- Suad Khalil, M.D. Child Neurology · East Lansing, MI
- Joel R. Saper, M.D. Pain Medicine · Ann Arbor, MI
- Brian E. Woodruff, MD Child Neurology · Saginaw, MI
- Robert A. Nahouraii, MD Child Neurology · Matthews, NC
- Warren D. Spinner, D.O. Neurology · Port Jefferson Station, NY
- Andrew D. Hershey, M.D. Child Neurology · Cincinnati, OH
- Jerry J. Tomasovic, MD Child Neurology · San Antonio, TX
- Ryan P. Williams, MD Child Neurology · Norfolk, VA
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Northwest Florida Clinical Res $90,542
- Cincinnati Childrens Hospital $31,932
- Multicare Neuroscience $30,440
- University of Kentucky Hospital, KY $26,938
- Yale University $25,377
- Jefferson Health $21,922
- The University of South Florida $19,723
- Spectrum Health System $18,007
- Road Runner Research LTD $14,111
- Childrens Specialty Group PLLC $11,482
- Onsite Clinical Solutions LLC $9,866
- Neostart Corporation DBA Aga C $9,702
- Michigan Headache and Neurological Institute $7,950
- University of Maryland Baltimore $7,435
- Michigan State University $7,429
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.